Valuation: Danaher Corporation

Market Cap 158B 140B 130B 118B 221B 14,933B 225B 1,560B 613B 7,815B 591B 579B 24,931B P/E 2026 *
38.2x
P/E 2027 * 30.9x
Enterprise Value 178B 159B 147B 133B 250B 16,882B 255B 1,764B 693B 8,835B 668B 655B 28,184B EV / Sales 2026 *
6.76x
EV / Sales 2027 * 6.1x
Free-Float
70.56%
Yield 2026 *
0.64%
Yield 2027 * 0.7%
1 day+3.12%
1 week+2.94%
Current month+4.40%
1 month+7.16%
3 months+29.21%
6 months+18.90%
Current year+1.04%
1 week 217.55
Extreme 217.55
233.02
1 month 211.18
Extreme 211.18
233.02
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 2026-09-30
Director of Finance/CFO - 2026-02-27
Chief Tech/Sci/R&D Officer - 2025-08-24
Director TitleAgeSince
Director/Board Member 74 1999-06-30
Chairman 74 1983-12-31
Director/Board Member 69 1983-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/9/26 Other

Director

205,860 0.0293%
10/9/26 Issuer sale

Founder

-500,000 0.0711%
10/9/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%+2.94%+4.77%+13.35% 158B
+0.98%+4.00%+25.48%+51.61% 254B
-4.41%+1.91%-7.45%+57.12% 155B
-1.82%+5.86%-54.43%-9.20% 66.06B
-0.38%+7.55%+10.33%+63.89% 51.6B
+0.47%+4.42%-13.91%-10.92% 51.82B
-1.14%+2.60%+16.68%+28.46% 50.89B
+2.07%+1.81%+21.60%+62.02% 48.78B
+2.06%+4.25%+30.33%+78.03% 43.51B
+3.61%+1.88%+179.77%+131.74% 40.46B
Average +0.50%+2.91%+21.32%+46.61% 91.96B
Weighted average by Cap. +0.27%+3.00%+13.90%+42.82%

Financials

2026 *2027 *
Net sales 26.35B 23.46B 21.74B 19.7B 37.02B 2,496B 37.64B 261B 102B 1,306B 98.85B 96.8B 4,168B 28.48B 25.35B 23.5B 21.29B 40.02B 2,698B 40.69B 282B 111B 1,412B 107B 105B 4,505B
Net income 4.18B 3.72B 3.45B 3.12B 5.87B 396B 5.97B 41.37B 16.25B 207B 15.68B 15.35B 661B 5.18B 4.61B 4.27B 3.87B 7.27B 491B 7.4B 51.25B 20.14B 257B 19.42B 19.02B 819B
Net Debt 20.57B 18.31B 16.97B 15.38B 28.9B 1,949B 29.38B 204B 79.99B 1,020B 77.16B 75.56B 3,253B 16.17B 14.4B 13.34B 12.09B 22.72B 1,532B 23.1B 160B 62.89B 802B 60.66B 59.41B 2,558B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
26-10-21 US$231.01 +3.02% 2,212,440
26-10-20 US$224.24 -0.08% 9,523,567
26-10-19 US$224.43 -2.01% 4,139,473
26-10-16 US$229.04 -1.06% 3,516,402
26-10-15 US$231.50 +3.03% 5,127,820
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
224.24USD
Average target price
244.14USD
Spread / Average Target
+8.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation